In this regard, elevated systemic MCP-1 system levels have been linked to worse outcomes in patients with cardiovascular disease (Martín-Ventura et al., 2009), and pulmonary accumulation of MCP-1 has been reported in patients with acute respiratory distress syndrome (Rosseau et al., 2000). Here, CCL2 is linked to acute respiratory distress syndrome.